Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Periodontal Disease: Therapeutic Strategies • Elimination of bacterial infection • Modulation of host response – mechanical removal of infectious – systemic delivery of hostagent modulating drugs – Triclosan toothpaste • NSAIDS – Antiseptic rinse/irrigation • Periostat® (SDD) – surgical reduction of periodontal • Bisphosphonates pockets – local delivery of host modulating – topical antimicrobials • Actisite® Modulation of risk factors drugs • Emdogain • Periochip –smoking cessation • Growth Factors • Atridox® –diabetic control • Arestin • BMPs –improved oral hygiene – systemic antimicrobials –corrective dentistry –improved nutrition –stress reduction –weight loss These Strategies are Complementary Colgate Total • Only toothpaste to contain triclosan, an antibacterial ingredient – Adheres to oral mucosa (soft and hard tissues) for up to 12 hours • Only toothpaste approved by FDA and Accepted by ADA for treatment of gingivitis, plaque, caries, calculus and oral malodor. Colgate Total Placebo controlled studies in smokers (Kerdvongbundit and Wikesjo, J Clin Periodontol. 2003;30(12):1024-30) and subjects with recurrent periodontitis (Furuichi et al., J Clin Periodontol. 1999;26(2):63-6) suggest that an oral hygiene regimen including a triclosan/copolymer dentrifice may sustain the short-term effect of non-surgical therapy in smokers and improve on healing after non-surgical treatment of recurrent periodontitis as measured by improvements in gingival inflammation, probing depth reductions and probing attachment levels. Colgate Total Triclosan in vitro has anti-inflammatory effects inhibiting cytokine (IL-1b and TNF-a) stimulated production of prostanoinds (PGE2) from monocytes and reducing the activity of an enzyme responsible for the production of prostanoids (COX-2) in culture, as well as inhibiting bone resorption in a parathyroidhormone-induced release of calcium from bone cultures. Intervention • Can periodontal therapy affect glycemic control in people with diabetes? • The first case series to demonstrate this was published in 1960 where type 1 diabetics with periodontitis had a reduction in required insulin doses following: – – – – Scaling and root planing Localized gingivectomy Selected tooth extraction Combined with penicillin and streptomycin Williams and Mahan, JAMA, 1960 Preliminary Intervention Trials Meta-analysis of 10 intervention trials included 456 patients • The decrease in absolute HbA1c values was ~0.4% • The addition of systemic antibiotics resulted in an average absolute reduction of 0.7% • Numerous deficiencies – Small sample sizes – Mixing type 1 and 2 diabetics – Confounding effects of smoking, BMI, medications, etc. • Additional studies are needed to determine whether periodontal therapy provides a significant benefit on glycemic control Janket S-J et al., J Dent Res, 2005 Raising The Bar • Glycated Hemoglobin – Lower and lower to prevent diabetic complications • Oral Care – Optimal to reduce insulin resistance and to allow for metabolic control – Improved to prevent long term complications – What is complete treatment, who is well controlled? • Is a 5 mm probing depth too much disease? • Is gingivitis too much disease?